Page 1 of 1

FDA Approves Recursion's CCM Drug for Phase I Trials!

PostPosted: Tue Jul 10, 2018 6:21 pm
by Connie Lee
BREAKING NEWS: Recursion has received FDA approval to begin clinical studies of a new medication called REC-994 for CCM! They plan to begin Phase I safety trials later this year (healthy volunteers participate to make sure the medication is safe in humans). A great milestone!

Read more here: https://www.prnewswire.com/news-releases/recursion-receives-fda-clearance-of-investigational-new-drug-application-to-initiate-first-clinical-trial-of-rec-994-in-cerebral-cavernous-malformation-300678055.html

Re: FDA Approves Recursion's CCM Drug for Phase I Trials!

PostPosted: Thu Jul 12, 2018 4:51 am
by Elizabeth
Wow!!! Awesome!!! Sounds very promising!!!